Literature DB >> 22654294

Blood transfusion transmitted infections in multiple blood transfused patients of Beta thalassaemia.

Prakash J Vidja1, J H Vachhani, S S Sheikh, P M Santwani.   

Abstract

Transfusion Transmitted Infection (TTI) continue to be a problem in many parts of world and multi-transfused patients of beta thalassaemia major are at a particularly increased risk of TTI. This study is aimed to estimate the prevalence of blood TTI in multiple blood transfused patients of beta thalassaemia major. Cross-sectional study of 200 multi-transfused patients of beta thalassaemia major, who were interviewed using a structured questionnaire and history was taken regarding sero-status of HIV (Human Immunodeficiency Virus), HBV (Hepatitis B Virus), HCV (Hepatitis C Virus) infection from their case papers. This study was conducted at the department of Pathology, M.P. Shah medical college, Jamnagar and Thalassemia ward, G.G. Hospital, Jamnagar (Gujarat, India) from March to May 2010. Out of 200 multiple blood transfused patients 7% patients were infected with TTI. Total 9 male patients and 5 female patients were infected with TTI. The seroreactivity for HIV was 3% (06/200); 1% (02/200) were males and 2% (04/200) were females. The seroreactivity for HBV was 2% (04/200) all were males. The seroreactivity for HCV was 2% (04/200); 1.5% (03/200) were males and 0.5% (01/200) was female. HIV, HBV, HCV infections are most prevalent TTI among multiple blood transfused patients of beta thalassemia major, and remains a major health problem for these patients.

Entities:  

Keywords:  Hepatitis B virus; Hepatitis C virus; Human immunodeficiency virus; Multiple blood transfused patients of beta thalassemia major; Transfusion transmitted infection

Year:  2011        PMID: 22654294      PMCID: PMC3136674          DOI: 10.1007/s12288-011-0057-3

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  12 in total

1.  Seroprevalence of hepatitis B and hepatitis C in patients with thalassemia and sickle cell anemia in a long-term follow-up.

Authors:  Sabahattin Ocak; Hasan Kaya; Meryem Cetin; Edip Gali; Muge Ozturk
Journal:  Arch Med Res       Date:  2006-10       Impact factor: 2.235

Review 2.  Iron and chronic viral hepatitis.

Authors:  H L Bonkovsky; B F Banner; A L Rothman
Journal:  Hepatology       Date:  1997-03       Impact factor: 17.425

3.  Survival and causes of death in thalassaemia major.

Authors:  M G Zurlo; P De Stefano; C Borgna-Pignatti; A Di Palma; A Piga; C Melevendi; F Di Gregorio; M G Burattini; S Terzoli
Journal:  Lancet       Date:  1989-07-01       Impact factor: 79.321

4.  Serological monitoring of thalassaemia major patients for transfusion associated viral infections.

Authors:  N Choudhury; S Saraswat; M Naveed
Journal:  Indian J Med Res       Date:  1998-06       Impact factor: 2.375

5.  HBV & HIV seropositivity in multi-transfused haemophilics & thalassaemics in eastern India.

Authors:  M De; D Banerjee; S Chandra; D K Bhattacharya
Journal:  Indian J Med Res       Date:  1990-01       Impact factor: 2.375

6.  Common transfusion-transmitted infectious agents among thalassaemic children in Bangladesh.

Authors:  Abid Hossain Mollah; Nazmun Nahar; Md A Siddique; Kazi Selim Anwar; Tariq Hassan; Md Golam Azam
Journal:  J Health Popul Nutr       Date:  2003-03       Impact factor: 2.000

7.  High frequency of hepatitis B virus infection in patients with beta-thalassemia receiving multiple transfusions.

Authors:  H Singh; M Pradhan; R L Singh; S Phadke; S R Naik; R Aggarwal; S Naik
Journal:  Vox Sang       Date:  2003-05       Impact factor: 2.144

8.  Risk factors for hepatitis B and C in multi-transfused patients in Uruguay.

Authors:  Lilia López; Patricia López; Antonio Arago; Ismael Rodríguez; Jorge López; Edgar Lima; Juan Insagaray; Nilo Bentancor
Journal:  J Clin Virol       Date:  2005-12       Impact factor: 3.168

9.  Transfusion-transmitted infections among multi-transfused patients in Brazil.

Authors:  Erich V de Paula; Neiva S L Gonçales; Serge Xueref; Marcelo Addas-Carvalho; Simone C O Gilli; Rodrigo N Angerami; Mônica P A Veríssimo; Fernando L Gonçales
Journal:  J Clin Virol       Date:  2005-12       Impact factor: 3.168

10.  The current risk of retroviral infections transmitted by transfusion in patients who have undergone multiple transfusions. Cooleycare Cooperative Group.

Authors:  D Prati; C Capelli; P Rebulla; F Mozzi; P Bosoni; C De Mattei; G Sirchia
Journal:  Arch Intern Med       Date:  1998-07-27
View more
  19 in total

Review 1.  Tackling the Hepatitis B Disease Burden in India.

Authors:  Pankaj Puri
Journal:  J Clin Exp Hepatol       Date:  2014-12-15

2.  Hydroxyurea (hydroxycarbamide) for transfusion-dependent β-thalassaemia.

Authors:  Saqib H Ansari; Zohra S Lassi; Salima M Khowaja; Syed Omair Adil; Tahir S Shamsi
Journal:  Cochrane Database Syst Rev       Date:  2019-03-16

3.  Transfusion transmitted infections in Indian thalassemics: a perspective.

Authors:  Ajit C Gorakshakar; Kanjaksha Ghosh
Journal:  Indian J Hematol Blood Transfus       Date:  2012-06-15       Impact factor: 0.900

Review 4.  Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India.

Authors:  Pankaj Puri; Anil C Anand; Vivek A Saraswat; Subrat K Acharya; Radha K Dhiman; Rakesh Aggarwal; Shivram P Singh; Deepak Amarapurkar; Anil Arora; Mohinish Chhabra; Kamal Chetri; Gourdas Choudhuri; Vinod K Dixit; Ajay Duseja; Ajay K Jain; Dharmesh Kapoorz; Premashis Kar; Abraham Koshy; Ashish Kumar; Kaushal Madan; Sri P Misra; Mohan V G Prasad; Aabha Nagral; Amarendra S Puri; R Jeyamani; Sanjiv Saigal; Shiv K Sarin; Samir Shah; P K Sharma; Ajit Sood; Sandeep Thareja; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2014-06-09

5.  A Cross-Sectional Study on Burden of Hepatitis C, Hepatitis B, HIV and Syphilis in Multi-Transfused Thalassemia Major Patients Reporting to a Government Hospital of Central India.

Authors:  Shrivastava Manisha; Kumar Sanjeev; Navaid Seema; Chotrani Dilip; Dwivedi Rashmi
Journal:  Indian J Hematol Blood Transfus       Date:  2014-10-12       Impact factor: 0.900

6.  Significance of Adopting Nucleic Acid Amplification Technique for Blood Donor Screening in a Resource Limited Setting: A Study from a Single Centre in South India.

Authors:  Sudha Ranganathan; Ranganathan N Iyer; Nagalla Balakrishna
Journal:  Indian J Hematol Blood Transfus       Date:  2021-10-27       Impact factor: 0.915

7.  Generic Direct Acting Antivirals in Treatment of Chronic Hepatitis C Infection in Patients of Thalassemia Major.

Authors:  Aabha Nagral; Smita Sawant; Nishtha Nagral; Pathik Parikh; Priya Malde; Rashid Merchant
Journal:  J Clin Exp Hepatol       Date:  2017-08-23

8.  Treatment of Chronic Hepatitis C Infection with Direct Acting Antivirals in Adolescents with Thalassemia Major.

Authors:  Aabha Nagral; Ajay Jhaveri; Smita Sawant; Nirzar Samir Parikh; Nishtha Nagral; Rashid Merchant; Mihir Gandhi
Journal:  Indian J Pediatr       Date:  2018-08-10       Impact factor: 5.319

9.  Study of serum haptoglobin level and its relation to erythropoietic activity in Beta thalassemia children.

Authors:  Seham M Ragab; Manal A Safan; Eman A Badr
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-02-15       Impact factor: 2.576

10.  Trend in Prevalence of Hepatitis C Virus Infection among β-thalassemia Major Patients: 10 Years of Experience in Iran.

Authors:  Maryam Jafroodi; Ali Davoudi-Kiakalayeh; Zahra Mohtasham-Amiri; Ali Akbar Pourfathollah; Azade Haghbin
Journal:  Int J Prev Med       Date:  2015-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.